Evidence map›Paper›PMID 32778734›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2021

Predictive modeling of estrogen receptor agonism, antagonism, and binding activities using machine- and deep-learning approaches.

Heather L Ciallella, Daniel P Russo, Lauren M Aleksunes, Fabian A Grimm, Hao Zhu

Open access · bronzeAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Development and application of consensusFrontiers in pharmacology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Heather L Ciallella *Center for Computational and Integrative Biology, Rutgers University, Camden, NJ, USA.
Daniel P Russo *Center for Computational and Integrative Biology, Rutgers University, Camden, NJ, USA.
Lauren M AleksunesDepartment of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA.
Fabian A GrimmExxonMobil Biomedical Sciences, Inc., Annandale, NJ, USA.
Hao ZhuCenter for Computational and Integrative Biology, Rutgers University, Camden, NJ, USA. hao.zhu99@rutgers.edu.
Rutgers, The State University of New Jersey · USExxonMobil (United States) · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI PANOS G. GEORGOPOULOS · 1988 to 2026
$47.4M
Placental Responses to Environmental Chemicals - Diversity Supplement 2R01ES029275 · NIEHS · RUTGERS, THE STATE UNIV OF N.J. · PI ALEKSUNES, LAUREN M, BARRETT, EMILY S · 2018 to 2022
$3.2M
Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for HepatotoxicityR01ES031080 · NIEHS · TULANE UNIVERSITY OF LOUISIANA · PI ZHU, HAO · 2020 to 2024
$2.3M
Predictive Computational Acute Toxicity Modeling by Profiling Chemicals With PublR15ES023148 · NIEHS · RUTGERS THE STATE UNIV OF NJ CAMDEN · PI ZHU, HAO · 2013 to 2018
$941k
NIEHS NIH HHS P30 ES005022NIEHS NIH HHS R01 ES029275NIEHS NIH HHS R01 ES031080NIEHS NIH HHS R15 ES023148
6 · The paper itself

Abstract

As defined by the World Health Organization, an endocrine disruptor is an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, its progeny, or (sub)populations. Traditional experimental testing regimens to identify toxicants that induce endocrine disruption can be expensive and time-consuming. Computational modeling has emerged as a promising and cost-effective alternative method for screening and prioritizing potentially endocrine-active compounds. The efficient identification of suitable chemical descriptors and machine-learning algorithms, including deep learning, is a considerable challenge for computational toxicology studies. Here, we sought to apply classic machine-learning algorithms and deep-learning approaches to a panel of over 7500 compounds tested against 18 Toxicity Forecaster assays related to nuclear estrogen receptor (ERα and ERβ) activity. Three binary fingerprints (Extended Connectivity FingerPrints, Functional Connectivity FingerPrints, and Molecular ACCess System) were used as chemical descriptors in this study. Each descriptor was combined with four machine-learning and two deep- learning (normal and multitask neural networks) approaches to construct models for all 18 ER assays. The resulting model performance was evaluated using the area under the receiver- operating curve (AUC) values obtained from a fivefold cross-validation procedure. The results showed that individual models have AUC values that range from 0.56 to 0.86. External validation was conducted using two additional sets of compounds (n = 592 and n = 966) with established interactions with nuclear ER demonstrated through experimentation. An agonist, antagonist, or binding score was determined for each compound by averaging its predicted probabilities in relevant assay models as an external validation, yielding AUC values ranging from 0.63 to 0.91. The results suggest that multitask neural networks offer advantages when modeling mechanistically related endpoints. Consensus predictions based on the average values of individual models remain the best modeling strategy for computational toxicity evaluations.

Indexed as

Machine LearningModels, StatisticalReceptors, EstrogenAlgorithmsAnimalsComputational BiologyDatabases, ChemicalDeep LearningEndocrine DisruptorsHumansMiceProtein BindingEndocrine DisruptorsReceptors, Estrogen

Identifiers

PMID32778734
PMCPMC7873171
OpenAlexW3048046837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.